Quarterly report pursuant to Section 13 or 15(d)

Significant Accounting Policies (Details)

v3.5.0.2
Significant Accounting Policies (Details)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2016
USD ($)
$ / shares
Sep. 30, 2015
$ / shares
Jun. 30, 2016
USD ($)
Sep. 30, 2016
USD ($)
item
$ / shares
Sep. 30, 2015
$ / shares
Dec. 31, 2013
USD ($)
Net Loss Per Share of Common Stock, Basic and Diluted            
Difference between basic net loss per share and diluted net loss per share | $ / shares $ 0 $ 0   $ 0 $ 0  
Restricted Cash [Abstract]            
Certificate of deposit supporting lease obligation           $ 175,000
Annual reduction permitted or requested in restricted cash, as a percent     33.00%     33.00%
Annual reduction permitted or requested in restricted cash     $ 58,000     $ 58,000
Number of periods reduction may be allowed           3 years
Security deposit required, end of third year           $ 13,000
Grant Revenue Recognition            
Revenue recognized on grant $ 321,497     $ 971,985    
Segment information            
Number of Operating Segments | item       1    
Computers and software            
Property and Equipment            
Property, Plant and Equipment, Useful Life       4 years    
Equipment [Member]            
Property and Equipment            
Property, Plant and Equipment, Useful Life       5 years    
Furniture and Fixtures [Member]            
Property and Equipment            
Property, Plant and Equipment, Useful Life       5 years    
National Institute On Drug Abuse (Member)            
Grant Revenue Recognition            
Research and development grant award       $ 1,000,000    
Revenue recognized on grant $ 321,497     971,985    
Proceeds received for revenue earned under grant       $ 592,729